Medisana SPRL
Medisana reported total assets of 112,622 € at the end of the 2025 financial year (annual accounts filed with the NBB on 16 Apr 2026).
The score of Medisana shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -2 % Total assets -1 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Medisana's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 16 Apr 2026
- Year ended 30 Sep 2024filed on 12 Feb 2025
- Year ended 30 Sep 2023filed on 25 Jan 2024
- Year ended 30 Sep 2022filed on 23 Feb 2023
- Year ended 30 Sep 2021filed on 31 Mar 2022
Medisana's financial analysis
- Solvency97.6%sector median: 41.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Medisana
Medisana's publications in the Belgian Gazette
No Belgian Gazette publication known for this company.
Company number, VAT number and registered office
- Company number (CBE)
- 0432.319.397
- VAT number
- BE0432319397
- Peppol
- Registered · 0208:0432319397 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 21 Oct 1987
- Registered office
- 1770 Liedekerke
- Latest accounts
- 2025 · filed on 16 Apr 2026
- Activity
- Intermediation service activities for real estate activities (NACE 68310)
Medisana (SPRL) has been based in Liedekerke since 1987, active in: intermediation service activities for real estate activities. For 2025, it reports a net loss of 737 € and equity of 109,911 €; its revenue is not published. Its solvency stands at 97.6%, above the median of its sector (41.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Medisana
Companies in the same business, of comparable size and area, outside its group.
- Linea Intermediation service activities for real estate activities Lennik · balance sheet 110,832 €
- Immobiliere VDG Intermediation service activities for real estate activities Soumagne · balance sheet 112,483 €
- Huis ID Intermediation service activities for real estate activities Gistel · balance sheet 112,326 €
- Wendimo Immobilien Intermediation service activities for real estate activities De Haan · balance sheet 112,939 €
- D&L Vastgoed Intermediation service activities for real estate activities Zoersel · balance sheet 113,050 €
- PMF Invest Intermediation service activities for real estate activities Herve · balance sheet 112,160 €
- Corners Services Intermediation service activities for real estate activities Uccle · balance sheet 113,120 €
- Soprombat Intermediation service activities for real estate activities Perwez · balance sheet 111,948 €
Frequently asked questions about Medisana
What is the revenue of Medisana?
Medisana files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Medisana?
In Belgium, the VAT number is the company number prefixed with BE: BE0432319397 for Medisana, if the company is VAT-registered. Its company number (CBE) is 0432.319.397.
Where is the registered office of Medisana?
According to the CBE register, the registered office of Medisana is in 1770 Liedekerke.
What is the equity of Medisana?
At the close of the 2025 financial year, the equity of Medisana amounts to 109,911 €, a solvency of 97.6% of total assets.
Who manages Medisana?
The register lists 1 active mandates at Medisana. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Medisana
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →